Histopathology and Biology of Testicular Germ Cell Tumor  by Pan, Chin-Chen
P R A C T I C A L  U R O PAT H O L O G Y
Urol Sci 2010;21(1):55−57
©2010 Taiwan Urological Association. Published by Elsevier Taiwan LLC. 55
Histopathology and Biology of Testicular 
Germ Cell Tumor
Chin-Chen Pan*
Department of Pathology, Taipei Veterans General Hospital and National Yang-Ming University, Taiwan
1. Introduction
The versatile histopathology, clinical presentation, and bi-
ologic behavior of testicular neoplasms reflect the com-
plex composition of the male gonad. Each component can 
develop different tumor types; thus, there are testicular 
germ cell tumor (TGT), sex cord/stromal tumor, miscel-
laneous tumors arising from rete testis or paratesticular 
structures, and tumors not specific to testicular paren-
chyma, such as lymphoma or mesenchymal neoplasms. All 
these varieties pose a challenge to both pathologists and 
clinicians regarding their diagnosis and treatment.
2. Nomenclature
Nowadays, the most widely adopted classification is the 
2004 World Health Organization (WHO) classification.1 
The terminology of the 2004 WHO classification is 
essentially the same as the classification for ovarian tu-
mors. However, one should bear in mind that the clin-
icopathologic features of testicular tumors are markedly 
different from those of ovarian tumors.
Other than the WHO classification, there are other 
terms that are no longer in use, such as “infantile embryo-
nal carcinoma”, which refers to pediatric yolk sac tumor, 
and “endodermal sinus tumor”, which is also equivalent to 
yolk sac tumor. In 1976, a divergent classification was pro-
posed by the British Testicular Tumor Panel, which intended 
to call most TGT as teratoma.2 However, the classification 
did not gain worldwide acceptance.
3. Relevance of Histopathologic Classification
The histopathologic classification of TGT is strongly as-
sociated with clinical features. In terms of age distribution, 
the incidence shows three age groups. In the infants and 
children, the majority of TGT are composed of yolk sac 
tumor and teratoma. In young adults in the third to fourth 
decade, seminoma and mixed germ cell tumors predom-
inate. Testicular tumors in men older than 50 years have 
a high frequency of malignant lymphoma. Spermatocytic 
seminoma is a rare tumor, and almost all occurs in the 
elderly.3
The histologic subtypes also reflect the degree of dif-
ferentiation and correlate with biologic behavior in respect 
to benignity versus malignancy. In the pediatric group, 
yolk sac tumor is malignant while all prepubertal testicu-
lar teratomas are benign even with immature histology. 
On the contrary, all postpubertal TGTs are malignant, even 
those with “benign” histology (mature teratoma) still have 
metastatic potential.4 The teratoma is considered the most 
differentiated form, while the embryonal carcinoma the 
most dedifferentiated one. Hence, the proportion of dif-
ferent elements may influence the overall prognosis.5,6
The different forms also dictate their metastatic route. 
Most of the TGT components metastasize to retroperito-
neal lymph nodes through lymphatics;7 meanwhile, the 
choriocarcinoma is notorious for its hematogenous spread 
owing to its propensity to invade vascular system even 
when the tumor is small. Therefore, choriocarcinoma 
can skip the retroperitoneal lymph nodes before it de-
velops widespread metastases.8
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The different subtypes correlate to the level of serum 
markers. Generally, the yolk sac tumor is associated with a 
high level of α-fetoprotein. The immature hepatoenteric 
component in teratoma can also moderately elevate 
α-fetoprotein levels. The high level of human chorionic 
gonadotropin usually indicates the presence of chorio-
carcinoma or scattered syncytiotrophoblasts.9 All these 
tests can provide useful clues for diagnosis and postop-
erative surveillance.
Finally, the different histologic subtypes have impli-
cation regarding the responsiveness to adjuvant therapy. 
Generally speaking, the seminoma is radiosensitive, and 
patients with pure seminoma of low stage are able to 
achieve long-term survival.10 Other non-teratomatous 
TGT components are responsive to multimodal therapy 
and high remission rate can be accomplished.3 On the 
contrary, teratomatous component is non-responsive to 
chemotherapy and radiotherapy. Consequently, surgical 
excision is the only modality to extirpate teratoma.
4.  Intratubular Germ Cell Neoplasia, 
Unclassified Type
When the tumor cells are confined in the seminiferous tu-
bules, it is called intratubular germ cell neoplasia.1 Among 
the groups of intratubular germ cell neoplasia, the intratu-
bular germ cell neoplasia, unclassified type (IGCNU) (for-
merly called carcinoma in situ)11 is considered a universal 
precursor of all testicular germ cell neoplasm except pedi-
atric teratoma and yolk sac tumor, spermatocytic semi-
noma, and dermoid cyst.3,8 IGCNU should be discerned 
from other specific forms of intratubular germ cell tumor, 
such as intratubular seminoma, intratubular embryonal 
carcinoma or intratubular choriocarcinoma, which repre-
sent intratubular involvement of invasive TGT.12
IGCNU is defined as presence of atypical cells resem-
bling the cells of invasive seminoma and demonstrating a 
characteristic distribution around the perimeter of sem-
iniferous tubule mingling with the non-neoplastic germ 
cells and the Sertoli cells (Figure 1).1,8 IGCNU has similar 
risk factors as invasive TGT, including cryptorchidism, infer-
tility and gonadal dysgenesis syndromes.8 IGCNU also ex-
hibits similar immunophenotype to that of seminoma, 
including placental alkaline phosphatase, CD117, OCT3/
4, NANOG and SOX2.8 Ploidy evaluation of IGCNU cells 
demonstrate a range of hypotriploidy to hypopentaploidy, 
but the isochromosome 12p gain observed in invasive 
TGT is absent in IGCNU.13 Clinically, about 50% of cases 
with IGCNU progressed into an invasive TGT within 5 years 
after identification, and only a small fraction of patients 
remain free of an invasive tumor by 7 or 8 years of follow-
up.14,15 These evidences lend further weight to the histo-
genetic role of IGCNU in TGT.
BA
Figure 1 (A) Intratubular germ cell neoplasia, unclassified type, characterized by atypical cells lining at the basal portion of the 
seminiferous tubules. (B) The neoplastic cells can be highlighted by immunohistochemical stain for placental alkaline phosphatase.
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Figure 2 Histogenetic model of testicular germ cell tumor. The 
intratubular germ cell neoplasia, unclassified type (IGCNU) is the 
initial step in the oncogenesis of postpubertal germ cells tumor 
except spermatocytic seminoma, while it is absent in the pediatric 
yolk sac tumor and teratoma. CC = choriocarcinoma; EC = embryo-
nal carcinoma; IMT = immature teratoma; MT = mature teratoma; 
p-T = pediatric teratoma; p-YST = pediatric yolk sac tumor; S = sem-
inoma; SS = spermatocytic seminoma; YST = yolk sac tumor.
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A model of TGT histogenesis has been advanced re-
cently (Figure 2).3 In the model, IGCNU plays a pivotal role 
as the first step of malignant transformation in adult TGT 
(except spermatocytic seminoma and dermoid cyst). When 
IGCNU acquires further mutation (e.g., isochromosome 
12p gain), it differentiates into various forms of TGT and 
mature teratoma is the most differentiated form. The 
model can explain many paradoxical behaviors of TGT. 
Since the tumors in the primary site and different meta-
static sites can differentiate into different forms, it is not 
surprising that the histology of metastatic tumor can differ 
from that of the primary tumor.
In contrast to most of adult TGT, the pediatric yolk 
sac tumor, pediatric teratoma, spermatocytic seminoma 
and dermoid cyst do not have IGCNU as precursor. 
Therefore, different mechanisms are involved in the his-
togenesis of those tumors. It also explains that these 
groups of tumor usually histologically manifest as pure 
form and have a more homogenous biologic behavior 
than that of adult TGT.
5. Extragonadal Germ Cell Tumor
Genuine germ cell tumors can arise in extragonadal sites, 
including the pineal region16 and mediastinum.17 However, 
it should be noted that many retroperitoneal germ cell 
tumors represent metastases from an occult or burn-out, 
spontaneous regressed, primary TGT. In this clinical con-
text, the absence of a palpable mass within the testis is 
insufficient to exclude its presence. Also, IGCNU may be 
found in the testes of patients of clinical extragonadal germ 
cell tumor, more commonly in the retroperitoneum than 
the mediastinum.18 If the possibility of metastatic germ 
cell tumor can be definitively excluded, the germ cell tu-
mors arising in the pineal region and mediastinum may 
represent a true extragonadal counterpart. These “true” 
extragonadal germ cell tumors are not related to IGCNU, 
and their biologic behavior is determined by histology 
and genetic alteration.16,17
6. Conclusion
The management of TGT is a paradigm of cooperation be-
tween the clinician and pathologist. Ultimate treatment is 
achieved with thorough clinical evaluation and complete 
pathologic examination. It is of utmost importance for clini-
cians to understand the terminology of TGT and its clinical 
relevance to tailor a satisfactory treatment and surveillance 
protocol for patients with TGT.
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